evaluation of the patient with dementia1747

Upload: paijo-suseno

Post on 03-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    1/39

    EVALUATION OF THEPATIENT WITH DEMENTIA

    Jonathan T. Stewart, MDProfessor in Psychiatry

    University of South Florida College of MedicineChief, Geropsychiatry SectionBay Pines VA Medical Center

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    2/39

    DEMENTIA

    A s y n d r o m e characterized by acqui red ,progress ive cognitive impairment

    Affects 10% of individuals over 65Caused by at least 80 different diseases,many reversible

    Unfortunately, the most common diseases (85

    90%) are irreversibleDiagnosis will have prognostic and treatmentimplicationsA ll dem ented p at ien ts n eed a wo rk-up

    and its mostly a good history

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    3/39

    PRIMARY SYMPTOMS

    ATTENTION

    MEMORYPOSTROLANDIC (COGNITION) EXECUTIVE (FRONTAL/SUBCORTICAL)INSIGHT

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    4/39

    PRIMARY SYMPTOMS

    ATTENTION: clouded sensorium, delirium

    MEMORY: forgetfulnessPOSTROLANDIC: aphasia, apraxia, gettinglostEXECUTIVE: poor judgment, disinhibition,abulia, urge incontinenceINSIGHT: anosognosia, catastrophicreactions

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    5/39

    TWO TYPES OF DEMENTIA

    Postrolandic

    Frontal/subcortical

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    6/39

    POSTROL NDIC

    Memory deficits Aphasia Apraxia Agnosia

    Personality more orless preservedMMSE valid

    FRONT L SUBCORTIC L

    Memory deficitsLoss of behavioral plasticityand adaptability, judgmentPersonality changes

    Disinhibition Abulia

    Urge incontinenceMMSE useless

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    7/39

    THE REST OF THE

    HISTORYTime course

    Depressive symptomsPast medical history

    Medical and psychiatric conditions

    Family HxEtOHMedications (including OTC, OPM)

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    8/39

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    9/39

    THE FOLSTEIN MMSE

    Most studied and used of the

    standardized examsQuick and easy to administerExcellent inter-rater reliability

    Accurately measures the severity andprogression of Alzheimers disease Does n o t detect execut iv e d efic i ts a t

    al l

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    10/39

    BEYOND THE MMSE

    ATTENTION: digit span or DLROW

    MEMORY: 3 word recall, orientationPOSTROLANDIC: naming, praxis,calculations, intersecting pentagons

    EXECUTIVE: contrasting programs,Luria figures, go-no go, controlled wordfluency, frontal release signs

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    11/39

    LURIAS RECURSIVEFIGURES

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    12/39

    LURIAS RECURSIVEFIGURES

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    13/39

    LURIAS RECURSIVEFIGURES

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    14/39

    THE GERIATRICDEPRESSION SCALE (GDS)

    Good screen for most patients

    Easy to administer and scoreFace- valid, so patients can fake goodor fake bad Valid for demented patients with anMMSE above about 12

    Use DMAS or Cornell scale for severelydemented patients

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    15/39

    THE REST OF THE WORK-

    UPBasic labsThyroid function testsB12 (methylmalonic acid andhomocysteine if borderline)SerologyHIV, drug screen, others, as indicatedNeuroimaging study, usuallyLP or EEG, rarely

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    16/39

    PLEASANT SURPRISES

    DepressionIatrogenic (anticholinergics, sedatives,narcotics, H2 blockers, multiple meds)HypothyroidismB12 deficiency

    Neurosyphilis Alcoholic dementiaNormal pressure hydrocephalusSubdural hematomaOthers

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    17/39

    POSTROLANDIC

    DEMENTIAS Alzheimers disease

    Diffuse Lewy body disease

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    18/39

    ALZHEIMERS DISEASE

    Slowly, insidiously progressive

    postrolandic dementia; executive sxsmuch laterNeurologic exam, labs, neuroimaging

    studies unremarkableOften familial, especially in youngerpatients

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    19/39

    ANTI-DEMENTIA DRUGS

    May improve cognitive function, ADLs to amodest extent; often ineffective

    Dechallenge if no meaningful benefitPossibly delay nursing home placementCholinesterase inhibitors may cause nausea,diarrhea, weight lossMemantine occasionally causes agitationTHESE A GENTS DO NOT SLOW THERA TE OF DECLINE

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    20/39

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    21/39

    BEWARE!

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    22/39

    DIFFUSE LEWY BODY

    DISEASESecond most common dementia in

    autopsy studiesCharacterized by Lewy bodiesthroughout the cortex

    Non-familial2:1 male:female ratio

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    23/39

    CLINICAL FEATURES

    Postrolandic dementiaMore rapidly progressive than AD

    Fluctuation, episodes of pseudodelirium common Mild parkinsonism

    Tremor often absentPoor response to antiparkinsonian medsShy- Drager sxs common

    Prominent psychotic sxs, esp visualhallucinations

    SEVERE NEUROL EPTIC INTOL ERA NCE

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    24/39

    FRONTAL/SUBCORTICAL

    DEMENTIASVascular dementiaFrontotemporal dementia and Picks disease

    Alcoholic dementiaHuntingtons disease, Wilsons disease, progressivesupranuclear palsy, late Parkinsons disease

    AIDS dementia complex, neurosyphilis, Lyme diseaseNormal pressure hydrocephalus

    Most head injuries Anoxia, carbon monoxideMultiple sclerosisTumorsANY ADVANCED DEMENTIA

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    25/39

    TYPES OF VASCULAR

    DEMENTIAMulti-infarct dementia

    Small vessel diseaseLacunar state (gray > white)Binswangers disease (white)

    Hemorrhagic vascular dementiaStrategic infarct dementiaDementia due to hypoperfusion

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    26/39

    SMALL VESSEL DISEASE

    At least 50% of all vascular dementia

    Often coexists with MIDUsual vascular risk factors, especiallyHPT

    Steady, not step-wise deteriorationRelatively more abulia than disinhibition

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    27/39

    FRONTOTEMPORAL DEMENTIA

    Relatively uncommon, non-familial

    illnessProminent (macroscopic) atrophy offrontal and anterior temporal cortex

    Symptoms include executive deficits,Klver-Bucy syndrome About 25% of pts have Pick bodies

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    28/39

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    29/39

    BEHAVIORAL PROBLEMS INDEMENTIA

    Present in 80% of cases

    Major source of caregiver stress,institutionalizationCommon at all stages of the disease

    Much more treatable than theunderlying dementiaPoorly described in the literature

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    30/39

    WOOF.

    MEDS OTHER

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    31/39

    THREE BASIC PRINCIPLES

    Simplicity

    Limited goalsThe no -fail environment

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    32/39

    THE CUSTOMERIS ALWAYS

    RIGHT!

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    33/39

    DEPRESSION

    20- 30% incidence in Alzheimers

    disease, often early in the course of theillnessMos t im po rtan t t reatab le caus e ofexc ess d isabi l i ty

    Responds very well to treatment

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    34/39

    ACUTE BEHAVIOR CHANGE

    I atrogenic

    I nfection I llness I njury I mpaction I nconsistency I s the patient depressed?

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    35/39

    AGITATION

    Present in up to 80% of patients

    Up to 34% of patients are combativeFew predictorsProbably a very heterogeneous problem

    Cornerstone of treatment isnonpharmacologic

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    36/39

    EMPIRICALLY EFFECTIVEMEDS FOR AGITATION

    Atypical neuroleptics (best when agitation isclearly related to delusions or hallucinations)

    AnticonvulsantsTrazodoneBeta-blockersBuspironeBenzodiazepinesOthers

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    37/39

    THE BEST NUMBER OFMEDICATIONS TO USE ISZERO (or sometimes one)

    WHEN IN DOUBT, GET RID OFMEDICATIONS!

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    38/39

    DONT FORGET SAFETYISSUES!

    DRIVING

    FIREARMSPOWER TOOLS

    SMOKING IN BED

    POISONS, MEDICATIONSFALL RISK

  • 8/12/2019 Evaluation of the Patient With Dementia1747

    39/39

    WOOF!

    MEDS OTHER

    GOOD LUCK!